If you have any questions regarding the content in this website, about the products that are mentioned, or just any questions at all don’t hesitate to contact me at the following address. I’d also love to hear any feedback on the site if you’ve found it helpful or have some ideas about how I can improve the site in some way.
Please contact me at support@naturaldiabetescures.net
With diabetes on the rise in the U.S., patient adherence to diabetes medications remains critical. Issues of affordability and price continue to impact patients’ willingness to start and stay on their medications. As a result, many diabetics drop medications in the middle of therapy, or fail to take prescriptions altogether.
Two new studies by CVS Caremark demonstrate successful interventions for improving adherence to diabetes medication. The first, published yesterday in the American Journal of Pharmacy Benefits, indicates that $0 generic co-pays and reduced co-pays can significantly improve medication adherence. Key outcomes include:
• Patients in value-based insurance plans (VBIDs) had significantly higher prescription initiation rates for both insulin and oral diabetes medicines
• Patients with VBIDs had significantly lower discontinuation rates for both insulin and oral diabetes medicines
The second, a case study published in this month’s American Journal of Health-System Pharmacists, demonstrates how an educational diabetes management program implemented by CVS Caremark in Polk County, Florida improved key clinical measurements for enrolled members and reduced emergency room visits and in-patient hospital admissions, after one year.
As part of the program, enrolled Polk County employees agree to work with the CVS Caremark clinical pharmacist, located on-site at the County’s employee health clinic, to develop individualized care plans and coordinate regular follow-up. Enrolled members receive co-pay waivers on disease-related medications (generic and preferred brands) as well as related supplies and non-prescription products.
Study outcomes include:
• After one year the reduction in glycosylated hemoglobin values (HbA(1c), a critical measurement of blood sugar levels) was especially high among members in the critical risk group, with nearly 78 percent of these members achieving a significant reduction.
• Medical claims data revealed a 30 percent decrease in all-cause hospitalizations and a 24 percent decrease in ER visits for enrolled members.